Contact Us | Careers

Corium Inc.
  • About Us
    • Leadership
    • Board of Directors
    • Our Mission
    • CVR Holders
  • Pipeline & Products
    • Alzheimer’s Disease
    • Contraception
  • Technology
    • R&D Capabilities
    • Corplex
    • MicroCor
  • Partnering
  • Manufacturing
  • News Releases
  • About Us
    • Leadership
    • Board of Directors
    • Our Mission
    • CVR Holders
  • Pipeline & Products
    • Alzheimer’s Disease
    • Contraception
  • Technology
    • R&D Capabilities
    • Corplex
    • MicroCor
  • Partnering
  • Manufacturing
  • News Releases

Archives

Monthly Archives: August 2015

August 26, 2015

By coriumi1-ca - Press Release

Corium Announces Issuance of U.S. Patent for MicroCor® Transdermal System for a Broad Range of Therapeutics and Vaccines
“Drug-in-Tip” Patent Provides Coverage of Dissolving Microstructure Arrays as an Alternative to Injections…

August 25, 2015

By coriumi1-ca - Press Release

Corium Initiates Phase 1 Clinical Trial of CorplexTM Donepezil Transdermal System for the Treatment of Alzheimer’s Disease
MENLO PARK, Calif. , Aug. 25, 2015 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced the commencement of dosing in a Phase 1…

August 5, 2015

By coriumi1-ca - Press Release

Corium Prices Follow-On Offering of Common Stock
MENLO PARK, Calif. , Aug. 5, 2015 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced the pricing of its underwritten public…

August 3, 2015

By coriumi1-ca - Press Release

Corium Announces Proposed Public Offering of Common Stock
MENLO PARK, Calif. , Aug. 3, 2015 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, announced today that it has commenced an underwritten public…

Archives

  • April 2019
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • March 2018
  • February 2018
  • December 2017
  • November 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • March 2017
  • February 2017
  • November 2016
  • October 2016
  • August 2016
  • July 2016
  • May 2016
  • March 2016
  • February 2016
  • January 2016
  • November 2015
  • August 2015
  • July 2015
  • May 2015
  • April 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • September 2014
  • August 2014
  • May 2014
  • April 2014
  • March 2014
  • December 2012
  • February 2011
  • May 2010
  • November 2009
  • November 2007
  • September 2007

Recent Posts

  • April 2, 2019
  • November 27, 2018
  • October 11, 2018
  • September 24, 2018
  • August 29, 2018
  • Home
  • About Us
  • Pipeline & Products
  • Technology
  • Partnering
  • Manufacturing
  • News Releases
  • Contact Us
  • Terms of Use
  • Privacy Policy








© 2019 Corium Inc. All rights reserved.